α2 adrenoceptors are involved in the regulation of the gripping-induced immobility episodes in taiep rats

Synapse

Volumn 60, Issue 5, 2006, Pages 362-370

  Eguibar, José R ^a,c   Cortés, Ma Del Carmen ^a   Valencia, Jaime ^a   Arias Montaño, José A ^b  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c NONE   (Mexico)

Author keywords

Cataplexy; Myelin mutants; Narcolepsy; Noradrenaline; REM sleep

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; IDAZOXAN; RAUWOLSCINE; XYLAZINE; YOHIMBINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATAXIA; BRAIN CORTEX; CATAPLEXY; CONTROLLED STUDY; DEMYELINATION; ELECTROMYOGRAPHY; EPILEPSY; HAND GRIP; HIPPOCAMPUS; MALE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REM SLEEP; TONIC IMMOBILITY; TREMOR; ANIMAL; ANIMAL BEHAVIOR; BINDING COMPETITION; BRAIN; DEMYELINATING DISEASE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETICS; METABOLISM; MOTOR DYSFUNCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOASSAY; RAT STRAIN; SPRAGUE DAWLEY RAT; WAKEFULNESS;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BEHAVIOR, ANIMAL; BINDING, COMPETITIVE; BRAIN; CATAPLEXY; CEREBRAL CORTEX; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; MOVEMENT DISORDERS; NOREPINEPHRINE; RADIOLIGAND ASSAY; RATS; RATS, MUTANT STRAINS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-2; SLEEP, REM; WAKEFULNESS;

EID: 33747050901     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20305     Document Type: Article

References (54)

1. Adler CH, Thorpy MJ. 2005. Sleep issues in Parkinson's disease. Neurology 64(12 Suppl. 3):S12-S20.
2. Aldrich MS. 1992. Narcolepsy. Neurology 42:34-43.
3. Aldrich MS. 1993. The neurobiology of narcolepsy-cataplexy. Prog Neurobiol 41:533-541.
4. Anch AM, Laposky AD. 2000. Rat sleep and eye movement density as a biological markers of demyelinating disease. Physiol Behav 71:269-275.
5. Aston-Jones G, Bloom FE. 1981. Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1:876-886.
6. Bourgin P, Huitron-Resendiz S, Spier AD, Fabre V, Morte B, Criado JR, Sutcliffe JG, Henriksen SJ, de Lecea L. 2000. Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons. J Neurosci 20:7760-7765.
7. Chan JY, Fung SJ, Chan SH, Barnes CD. 1986. Facilitation of lumbar monosynaptic reflexes by locus coeruleus in the rat. Brain Res 369:103-109.
8. Chemelli RM, Willie JT, Sinton ChM, Elmquist JK, Scammell T, Lee C, Richardson JA, Williams SC, Xiong Y, Kisanuki Y, Fitch TE, Nakazato M, Hammer RE, Saper CB, Yanagisawa M. 1999. Narcolepsy in orexin knock-out mice: Molecular genetics on sleep regulation. Cell 98:437-451.
9. Cortés MC, Gavito B, Eguibar JR. 2000. Catecholaminergic uptake inhibitors decrease gripping-induced immobility episodes in a mutant taiep rat. Soc Neurosc 26:1514 (abstract).
10. Cortés MC, Ita ML, Moyaho A, Eguibar JR. 2004. The sleep-wake cycle of taiep rats is disorganized. Soc Neurosc Abstract 764.2.
11. Cortés MC, Gavito B, Ita ML, Valencia J, Eguibar JR. 2005. Characterization of the spontaneous and gripping-induced immobility episodes on taiep rats. Synapse 58:95-101.
12. Couve E, Cabello F, Krsulovic J, Roncagliolo M. 1997. Binding of microtubules to transitional elements in oligodendrocytes of the myelin mutant taiep rat. J Neurosci Res 47:573-581.
13. Duncan ID, Lunn KF, Holmgren B, Urbá-Holmgen R, Brignolo-Holmes L. 1992. The taiep rat: A myelin mutant with an associated oligodendrocyte microtubular defect. J Neurocytol 21:870-884.
14. Eguibar JR, Cortés MC, Ita ML, Moyaho A. 2004. Spontaneous immobility episodes (IEs) in the taiep rat have REM-sleep characteristics. Soc Neurosc Abstract 764.1.
15. 1 binding in basal ganglia. Brain Res 956:24-29.
16. Foote AK, Blakemore WF. 2005. Repopulation of oligodendrocyte progenitor cell-depleted tissue in a model of chronic demyelination. Neuropathol Appl Neurobiol 31:374-383.
17. Foutz AS, Delashaw JB Jr, Guilleminault C, Dement WC. 1981. Monoaminergic mechanisms and experimental cataplexy. Ann Neurol 10:369-376.
18. Goldberg MR, Robertson D. 1983. Yohimbine: A pharmacological probe for study of the α 2-adrenoreceptor. Pharmacol Rev 35:143-180.
19. Gulyani S, Wu MF, Nienhuis R, John J, Siegel JM. 2002. Cataplexy-related neurons in the amygdala of the narcoleptic dog. Neuroscience 112:355-365.
20. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30:345-354.
21. Holmgren B, Urbá-Holmgren R, Riboni L, Vega-Saenz de Miera EC. 1989. Sprague-Dawley rat mutant with tremor, ataxia, tonic immobility episodes, epilepsy and paralysis. Lab Anim Sci 39:226-228.
22. Hoyt BD. 2005. Sleep in patients with neurologic and psychiatric disorders. Prim Care 32:535-548.
23. Krsulovic J, Couve E, Roncagliolo M. 1999. Dysmyelination, demyelination and reactive astrogliosis in the optic nerve of the taiep rat. Biol Res 32:253-262.
24. León-Chavez BA, Guevara J, Galindo S, Luna J, Ugarte A, Villegas O, Mena R, Eguibar JR, Martinez-Fong D. 2001. Regional and temporal progression of reactive astrocytosis in the brain of the myelin mutant taiep rat. Brain Res 900:152-155.
25. León-Chavez BA, González-Barrios JA, Ugarte A, Meraz MA, Martinez-Fong D. 2003. Evidence in vitro of glial cell priming in the taiep rat. Brain Res 965:274-278.
26. Li FY, Song J, Duncan ID. 2003. Mapping of taiep rat phenotype to rat Chromosome 9. Mamm Genome 14:703-705.
27. Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X, Qiu X, Jong PJ, Nishino S, Mignot E. 1999. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gen. Cell 98:365-376.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
29. Lunn KF, Clayton MK, Duncan ID. 1997. The temporal progression of the myelination defect in the taiep rat. J Neurocytol 26:267-281.
30. Martínez I, Eguibar JR, Flores G. 2005. Disminución de la arborización dendrítica y densidad de espinas dendríticas de las neuronas piramidales de la corteza prefrontal y parietal en la rata mutante taiep. XLVIII Soc Mex Ciencias Fisiológ Abstract C-107.
31. Mefford IN, Baker TL, Boehme R, Foutz AS, Ciaranello RD, Barchas JD, Dement WC. 1983. Narcolepsy: Biogenic amine deficits in an animal model. Science 220:629-632.
32. Mignot E, Guilleminault C, Bowersox S, Rappaport A, Dement WC. 1988. Effect of α 1-adrenoceptors blockade with prazosin in canine narcolepsy. Brain Res 444:184-188.
33. Mileykovskiy BY, Kiyashchenko LI, Kodama T, Lai YY, Siegel JM. 2000. Activation of pontine and medullary motor inhibitory regions reduces discharge in neurons located in the locus coeruleus and the anatomical equivalent of the midbrain locomotor region. J Neurosci 20:8551-8558.
34. Miller JD, Faull KF, Bowersox SS, Dement WC. 1990. CNS monoamines and their metabolites in canine narcolepsy: A replication study. Brain Res 509:169-171.
35. Möller JR, Durr PG, Quarles RH, Duncan ID. 1997. Biochemical analysis of myelin proteins in a novel neurological mutant: The taiep rat. J Neurochem 69:773-779.
36. Nishino S, Mignot E. 1997. Pharmacological aspects of human and canine narcolepsy. Prog Neurobiol 52:27-78.
37. Nishino S, Haak L, Shepherd H, Guilleminault C, Sakai T, Dement WC, Mignot E. 1990. Effects of central α-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep. J Pharmacol Exp Ther 253:1145-1152.
38. Nishino S, Reid MS, Dement WC, Mignot E. 1994. Neuropharmacology and neurochemistry of canine narcolepsy. Sleep 17:S84-S92.
39. O'Connor LT, Gotees BD, Couve E, Song J, Duncan ID. 2000. Intracellular distribution of myelin protein gene products is altered in oligodendrocytes of the taiep rat. Mol Cell Neurosci 16:396-407.
40. 2-mediated muscle relaxation. Neuroscience 34:177-187.
41. Prieto GJ, Urbá-Holmgen R, Holmgren B. 1991. Sleep and EEG disturbances in a rat neurological mutant (taiep) with immobility episodes: A model of narcolepsy-cataplexy. Electroencephalogr Clin Neurophysiol 79:141-147.
42. Reggiani P, Magrini F, Mondadori C, Branzi G, Zanchetti A. 1989. Marked blood pressure fluctuations during narcoleptic attacks alternating with abnormal wakefulness: Effects of treatment with clonidine. Eur Heart J 10:2-7.
43. Renaud A, Nishino S, Dement WC, Guilleminault C, Mignot E. 1991. Effects of SDZ NVI-085, a putative subtype-selective α 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep. Eur J Pharmacol 205:11-16.
44. Roncagliolo M, Benitez J, Eguibar JR. 2000. Progressive deterioration of central components of auditory brainstem responses during postnatal development of the myelin mutant taiep rat. Audiol Neurootol 5:267-275.
45. Roncagliolo M, Schlageter C, Leon C, Couve E, Bonansco C, Eguibar JR. 2006. Developmental impairment of compound action potential in the optic nerve of myelin mutant taiep rats. Brain Res 1067:78-84.
46. Siegel JM, Nienhuis R, Fahringer HM, Paul R, Shiromani P, Dement WC, Mignot E, Chiu C. 1991. Neuronal activity in narcolepsy: Identification of cataplexy-related cells in the medial medulla. Science 252:1315-1318.
47. Snedecor GW, Cochran WG. 1989. Statistical methods. Ames, IA: Iowa State Univ Press p 491.
48. Song J, O'Connor LT, Yu W, Baas PW, Duncan ID. 1999. Microtubule alterations in cultured taiep rat oligodendrocytes lead to deficits in myelin membrane formation. J Neurocytol 28:671-683.
49. Song J, Goetz BD, Kirvell SL, Butt AM, Duncan ID. 2001. Selective myelin defects in the anterior medullary velum of the taiep mutant rat. Glia 33:1-11.
50. Valencia J, Aceves J. 1992. Spontaneous rigidity recorded in a mutant rat (taiep) with immobility episodes. Soc Neurosci 18:1594 (abstract).
51. Valencia J, Calderón R. 2001. Striatal dopamine release in the mutant rat (taiep) J Neurochem 78:47.
52. White SR, Neuman RS. 1980. Facilitation of spinal motoneurone excitability by 5-hydroxytryptamine and noradrenaline. Brain Res 188:119-127.
53. Wooten V. 1994. Effectiveness of yohimbine in treating narcolepsy. South Med J 87:1065,1066.
54. Wu MF, Gulyani SA, Yau E, Mignot E, Phan B, Siegel JM. 1999. Locus coeruleus neurons: Cessation of activity during cataplexy. Neuroscience 91:1389-1399.